Forward Citations = 0

Loading Chart...

23 inventors (with patents filed for the assignee):

Jinchao Zhang (2 out of 3 patents)

Chang Zhang (2 out of 2 patents)

Shasha Jiao (2 out of 2 patents)

4. Shuang Wang (2 out of 3 patents)

5. Dadi Zeng (2 out of 2 patents)

6. Rongjuan Wang (2 out of 2 patents)

7. Jian Zhu (1 out of 18 patents)

8. Jian Lin (1 out of 9 patents)

9. Jin Wang (1 out of 36 patents)

10. Lichun Wang (1 out of 8 patents)

11. Wei Wu (1 out of 32 patents)

12. Kai Zhong (1 out of 2 patents)

13. Xing Li (1 out of 4 patents)

14. Jiao Zhang (1 out of 6 patents)

15. Yang Zhang (1 out of 41 patents)

4 patents: Sort by Forward Citations

1. 12715904 - TGF-BETA RII MUTANT AND FUSION PROTEIN THEREOF (2026-08-25),

2. 12624112 - ANTI-ST2 ANTIBODY, ENCODING NUCLEIC ACID MOLECULES THEREOF AND METHODS OF USE THEREOF (2026-05-12),

3. 12590150 - ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF (2026-03-31),

4. 12558577 - ANTI-HUMAN TROP-2 ANTIBODY AND APPLICATION THEREOF (2026-02-24),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#540 in SHANGHAI

#6,375 in China

Shanghai, China

Mabwell (Shanghai) Bioscience Co., Ltd.

Forward Citations = 0

23 inventors:

Jinchao Zhang (2 out of 3 patents)

Chang Zhang (2 out of 2 patents)

Shasha Jiao (2 out of 2 patents)

4. Shuang Wang (2 out of 3 patents)

5. Dadi Zeng (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mabwell (Shanghai) Bioscience Co., Ltd.. Retrieved from https://idiyas.com/company/mabwell-shanghai-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]